Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
Yahoo Finance · 2 weeks ago
Open | 48.94 |
High | 49.46 |
Low | 47.42 |
Mkt Cap | 3.74B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 48.63 |
52 Wk. Low | 15.76 |
52 Wk. High | 53.70 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 640k | 76.10% ▼ |
Net Income | -66.93M | - |
Diluted EPS | -0.93 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.86 | - |
Q1 2024 | -$0.81 | -$0.93 |
Q4 2023 | -$0.86 | -$0.90 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.29 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.79 (+1.10%) |
Ethereum USDETH-USD | 3,831.99+2.41% |
UiPath Inc.PATH | 18.98-0.32% |
7.21-2.83% |